Compare BDTX & TONX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BDTX | TONX |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | 23 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.8M | 134.0M |
| IPO Year | 2020 | N/A |
| Metric | BDTX | TONX |
|---|---|---|
| Price | $2.69 | $2.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $9.50 | N/A |
| AVG Volume (30 Days) | ★ 619.0K | 403.1K |
| Earning Date | 05-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 130.71 | N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.82 | ★ $0.26 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.31 | $1.75 |
| 52 Week High | $4.94 | $8.23 |
| Indicator | BDTX | TONX |
|---|---|---|
| Relative Strength Index (RSI) | 65.58 | 49.79 |
| Support Level | $2.45 | $1.80 |
| Resistance Level | $2.86 | $3.61 |
| Average True Range (ATR) | 0.15 | 0.24 |
| MACD | 0.06 | -0.02 |
| Stochastic Oscillator | 91.33 | 46.67 |
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
TON Strategy Co is a leader in interactive video-based sales applications, transforms how businesses attract and engage customers. The company's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.